The company said it plans to expand into new supply chains for advanced therapeutics in addition to cell and gene therapies, as well as expanding its footprint in Europe and the Asia-Pacific region.
The Series E round, which was led by existing investors General Catalyst and Kinnevik, included participation from Merck Global Health Innovation Fund, Microsoft Ventures and others.
A new independent study from Phyx Primary Care’s Innovation Lab points to measurable improvements in physician burnout, documentation efficiency, and key VBC metrics among primary care practices.
Seattle-based Xealth, a new startup out of Providence Health & Services, has nabbed $8.5 million in a round led by DFJ. The company's platform lets physicians prescribe digital health content, apps and services.
The company rebranded from ElationEMR and added DFJ as a backer, along with a couple of angel investors.